Cartesian Therapeutics, Inc. (RNAC)
NASDAQ · Manufacturing · Pharmaceutical preparations
$7.42−$0.2000 (−2.62%) on the dayAs of the close; data may be delayed.
RNAC price, last 12 months
Key stats
- Previous close
- $7.62
- Open
- $7.55
- Day range
- $7.31 – $7.60
- 52-week range
- $5.60 – $11.00
- Volume
- 131.1K
- Avg volume (20 days)
- 120.1K
- Market cap
- $224.2M
Performance
1W−7.6%
1M−27.2%
3M−21.2%
6M+22.0%
YTD+2.9%
1Y−26.3%
vs S&P 500, 1Y−43.1 pts
Technicals and fundamentals
About Cartesian Therapeutics, Inc.
Cartesian Therapeutics Inc is a clinical-stage biopharmaceutical company pioneering cell therapy for the treatment of autoimmune diseases. The company uses technology and a manufacturing platform to introduce mRNA into cells to provide a therapeutic effect to patients suffering from a variety of autoimmune conditions. Unlike DNA, mRNA degrades naturally over time without integrating into the cell's genetic material.
- Sector
- Manufacturing
- Industry
- Pharmaceutical preparations
- Listed on
- NASDAQ
- Market cap
- $224.2M